scholarly journals Pityriasis rosea infection in a COVID ‐19 patient successfully treated with systemic steroid and antihistamine via telemedicine: literature update of a possible prodromal symptom of an underlying SARS‐CoV ‐2 infection

2021 ◽  
Author(s):  
Giovanni Paolino ◽  
Matteo Riccardo Di Nicola ◽  
Carmen Cantisani ◽  
Santo Raffaele Mercuri
Keyword(s):  
Prodromal Symptom ◽  
Systemic Steroid ◽  
Pityriasis Rosea

scholarly journals Clinical profile of pityriasis rosea: a descriptive study from urban Karnataka

2019 ◽  
Vol 5 (3) ◽  
pp. 637
Author(s):  
Dayanand Raikar ◽  
Mohammed Waseem Javed ◽  
Anant A. Takalkar
Keyword(s):  
Acne Vulgaris ◽  
Unknown Origin ◽  
Sudden Onset ◽  
Clinical Profile ◽  
Prodromal Symptom ◽  
Age Group ◽  
Pityriasis Rosea ◽  
Male Predominance ◽  
Medical College ◽  
History Of

<p class="abstract"><strong>Background:</strong> Pityriasis rosea (PR) is common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years). It has a sudden onset, and in its typical presentation, the eruption is proceeded by a solitary patch termed “herald patch”, mainly located on the trunk. The objective of the study was to assess the clinical profile of pityriasis rosea.</p><p class="abstract"><strong>Methods:</strong> The data was collected from patients attending the Department of Dermatology, Basaveshwar Teaching and General Hospital attached to Mahadevappa Rampure Medical College, Gulbarga. It is a descriptive observational study. A total 79 patients suffering from pityriasis rosea who attended the outpatient department were included in the present study during the period from 2006 to 2007.<strong></strong></p><p class="abstract"><strong>Results:</strong> Out of 79 patients studied, majority were from 11-20 years age group 33 (41.8%) followed by 27.8% from 21-30 years age group. The mean age of study population was found to be 21.3±6.4 years. 11% gave history of acne vulgaris, 8% each had history of atopy and drugs. Commonly observed prodromal symptoms were URTI (25.3%) and fever (17.7%). Herald patch was seen on trunk in majority of patients i.e. 36 (61%) followed by 18.6% cases on upper extremity and on neck (8.5%).</p><p class="abstract"><strong>Conclusions:</strong> Our study concludes that pityriasis is common in 11-20 years age group with male predominance having URTI as common prodromal symptom and typical rash.</p>

Vesicular pityriasis rosea

1977 ◽  
Vol 113 (12) ◽  
pp. 1733b-1734 ◽  
Author(s):  
A. Griffiths
Keyword(s):  
Pityriasis Rosea

Azithromycin No Use for Pityriasis Rosea

2006 ◽  
Vol 36 (16) ◽  
pp. 30
Author(s):  
ROBERT FINN
Keyword(s):  
Pityriasis Rosea

A Case of Allergic Granulomatous Angiitis with Peripheral Blood Eosinophilia Revealing Resistance to Systemic Steroid

2006 ◽  
Vol 68 (1) ◽  
pp. 19-23
Author(s):  
Yuki SUZUKI ◽  
Hideaki WATANABE ◽  
Amane KITAMI ◽  
Hirohiko SUEKI ◽  
Masafumi IIJIMA ◽  
...  
Keyword(s):  
Peripheral Blood ◽  
Systemic Steroid ◽  
Granulomatous Angiitis ◽  
Blood Eosinophilia ◽  
Allergic Granulomatous Angiitis ◽  
Peripheral Blood Eosinophilia

scholarly journals The clinics of HHV ‐6 infection in COVID ‐19 pandemic: Pityriasis rosea and Kawasaki disease

2020 ◽  
Vol 33 (4) ◽  
Author(s):  
Recep Dursun ◽  
Selami Aykut Temiz
Keyword(s):  
Kawasaki Disease ◽  
Pityriasis Rosea

scholarly journals “Pityriasis rosea, COVID‐19 and vaccination: new keys to understand an old acquaintance”

2021 ◽  
Author(s):  
JM Busto‐Leis ◽  
G Servera‐Negre ◽  
A Mayor‐Ibarguren ◽  
E Sendagorta‐Cudós ◽  
M Feito‐Rodríguez ◽  
...  
Keyword(s):  
Pityriasis Rosea

scholarly journals SARS‐CoV‐2 Spike Protein Positivity in Pityriasis Rosea‐like and Urticaria‐like Rashes of COVID‐19

2021 ◽  
Author(s):  
E. Welsh ◽  
J.A. Cardenas‐de la Garza ◽  
A. Cuellar‐Barboza ◽  
R. Franco‐Marquez ◽  
R.I. Arvizu‐Rivera
Keyword(s):  
Spike Protein ◽  
Pityriasis Rosea
Sign in / Sign up

Export Citation Format

Share Document